Cancer-associated fibroblasts show heterogeneous gene expression and induce vascular endothelial growth factor A (
VEGF‐A
cancer‐associated fibroblast
complex system
heterogeneity
perturbation
Journal
Annals of gastroenterological surgery
ISSN: 2475-0328
Titre abrégé: Ann Gastroenterol Surg
Pays: Japan
ID NLM: 101718062
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
05
11
2018
revised:
05
03
2019
accepted:
15
03
2019
entrez:
27
7
2019
pubmed:
28
7
2019
medline:
28
7
2019
Statut:
epublish
Résumé
Cancer-associated fibroblasts (CAF) play a crucial role in angiogenesis in the complex tumor microenvironment. However, fibroblasts show extensive heterogeneity and their dynamic functions against stressors remain largely unknown. We collected patient-derived CAF and carried out perturbation-based monitoring of the dynamic functions. Clinically relevant experimental stimuli were defined as follows: hypoxia, cisplatin, fluorouracil, coculture with cancer spheroids (interaction through paracrine signals). We selected 18 marker genes that encode components for fibroblast activation, intracellular communication, and extracellular matrix remodeling. Quantitative reverse transcription polymerase chain reaction was carried out for data collection and statistical analyses were carried out using SPSS software. Kruskal-Wallis multivariate analysis of variance showed that variations in expression of 11 marker genes were explained, in part, by a difference in tissue of origin. Friedman and two-sided Wilcoxon signed rank tests detected significant perturbations in expression of marker genes. Paracrine signal from cancer spheroids induced vascular endothelial growth factor A ( We have established perturbation-based monitoring of patients' CAF. Further data collection and individual patient follow up is ongoing to identify critical determinants of disease outcome.
Identifiants
pubmed: 31346581
doi: 10.1002/ags3.12249
pii: AGS312249
pmc: PMC6635680
doi:
Types de publication
Journal Article
Langues
eng
Pagination
416-425Références
Nat Rev Drug Discov. 2013 May;12(5):347-57
pubmed: 23584393
Cancer Res. 2017 Nov 15;77(22):6065-6068
pubmed: 28754675
Cancer Res. 2017 Jun 15;77(12):3364-3375
pubmed: 28381545
Nat Cell Biol. 2014 Aug;16(8):717-27
pubmed: 25082194
Islets. 2016 Sep 2;8(5):135-44
pubmed: 27415824
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
N Engl J Med. 1999 Sep 2;341(10):738-46
pubmed: 10471461
Mol Cancer Ther. 2018 Jul;17(7):1515-1525
pubmed: 29643149
Nat Genet. 2015 Oct;47(10):1168-78
pubmed: 26343385
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
Mol Cancer. 2017 Apr 3;16(1):73
pubmed: 28372546
J Exp Med. 2017 Mar 6;214(3):579-596
pubmed: 28232471
Ann Gastroenterol Surg. 2019 Apr 09;3(4):416-425
pubmed: 31346581
Nat Med. 2015 Aug;21(8):938-945
pubmed: 26193342
Science. 1961 Nov 10;134(3489):1501-6
pubmed: 14471768
Nat Genet. 2015 Apr;47(4):320-9
pubmed: 25706628
Cancer Cell. 2012 Mar 20;21(3):309-22
pubmed: 22439926
Oncology. 2015;88(5):309-19
pubmed: 25591719
Cancer Med. 2016 Sep;5(9):2544-57
pubmed: 27485632
PLoS Genet. 2006 Jul;2(7):e119
pubmed: 16895450
Nat Rev Gastroenterol Hepatol. 2012 Aug;9(8):454-67
pubmed: 22710569
Nat Med. 2017 Sep 8;23(9):1028-1035
pubmed: 28886003
Nat Rev Cancer. 2017 May;17(5):302-317
pubmed: 28303905